NCT05841381 Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT05841186 Correlation of Timing of Pegfilgrastim Administration and PIBP. Status RECRUITING Phase NA
NCT05839288 Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients Status COMPLETED Phase N/A
NCT05838417 Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study Status COMPLETED Phase NA
NCT05838001 Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy Status RECRUITING Phase NA
NCT05837455 NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer Status RECRUITING Phase PHASE2
NCT05837169 Randomized Study to Evaluate an Intervention Based on Mindfulness to Reduce Anxiety in Breast Cancer Survivors Status COMPLETED Phase NA
NCT05836337 Clinical Trial Evaluating the Effectiveness of a Tattoo Compared to a Clip Applied to Axillary Lymph Nodes in Breast Cancer Patients Who Undergo SLNBx Status COMPLETED Phase NA
NCT05835739 InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2 Status RECRUITING Phase N/A
NCT05834699 HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC Status UNKNOWN Phase N/A
NCT05834686 HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC Status UNKNOWN Phase N/A
NCT05832138 ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario Status NOT_YET_RECRUITING Phase NA
NCT05831397 Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy Status RECRUITING Phase N/A
NCT05830461 Online Psychological Care Program for Women Who Attend a Breast Clinic. Status UNKNOWN Phase NA
NCT05826964 Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05825768 Preoperative Magnetic Resonance Imaging to Obtain Adequate Resection Margins in Breast Conserving Surgery, (PRIMAR) Trial Status TERMINATED Phase NA
NCT05825547 Evaluation of Changes in the Immunological Microenvironment Surrounding Subcutaneous Breast Cancer Metastases After Liquid Nitrogen Cryotherapy Status COMPLETED Phase NA